Wolfgang Wienand, CEO of Lonza, Outlines ‘One Lonza’ Strategy and 2025 Growth Targets

Lonza has provided an overview of its new “One Lonza” strategy and new organizational structure As Lonza focuses on its core CDMO1 busines...

December 12, 2024 | Thursday | News
Shaping Biopharma Purification: Phenomenex’s Vision for 2025

Matt Boag, Biopharmaceutical Product Marketing Manager at Phenomenex, discusses the transformative innovations shaping plasmid DNA, mRNA, and peptide purif...

December 12, 2024 | Thursday | Opinion
Innovating for Impact: Venkata Indurthi on Aldevron’s Vision for Biomanufacturing in 2025

  In a compelling conversation with BioPharma BoardRoom, Venkata Indurthi, Chief Scientific Officer at Aldevron, shares insights into the inn...

December 12, 2024 | Thursday | Interaction
Redefining Precision Medicine: Demaris Mills on IDT’s Role in Precision Medicine and Gene Synthesis for 2025

In a thought-provoking Q&A with BioPharma BoardRoom, Demaris Mills, President of Integrated DNA Technologies (IDT), discusses the transformative advanc...

December 12, 2024 | Thursday | Interaction
Building a Sustainable Future: Cytiva’s 2025 Roadmap for Transforming Biopharma

As the biopharma industry continues to evolve, sustainability has emerged as a key driver of progress. Ryan Walker, Sustainability Program Leader at Cyt...

December 12, 2024 | Thursday | Opinion
2025 M&A Outlook: Transforming Biopharma and Biotech Through Strategic Innovation

  As 2025 unfolds, the pharmaceutical, biopharmaceutical, and biotechnology industries are on the brink of a transformative shift. With mergers and a...

November 28, 2024 | Thursday | Analysis
Ex-Pfizer Titans Stand Firm, Defiantly Back CEO Amid Activist Investor Storm, Betting on a Bold Long-Term Gamble for Shareholder Value

In an exclusive statement released through Guggenheim Securities, LLC, former Pfizer CEO Ian Read and former CFO Frank D’Amelio addressed growing s...

October 10, 2024 | Thursday | Analysis
IDT Pioneers CRISPR Safety and Accuracy with Advanced Technologies

  In a recent Q&A session with BioPharma BoardRoom, Gavin Kurgan, Bioinformatics Applications Development Manager at Integrated DNA Technologies ...

July 29, 2024 | Monday | Interaction
Global Cancer Cases Set to Surge to 32 Million Annually by 2050, with Dramatic Increases in Low-Income Countries

Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a pot...

June 11, 2024 | Tuesday | Reports
Hepatitis: The silent killer

May is Hepatitis Awareness Month, the perfect time for individuals to talk to their health care providers about hepatitis vaccinations. Hepatitis is an inf...

May 20, 2024 | Monday | Reports
Driving Global Access to Medicines: A Conversation with Cem Zorlular, CEO of Er-Kim

  In an interview with BioPharma BoardRoom, Cem Zorlular, CEO of Er-Kim, shares his personal journey and the driving force behind Er-Kim's mission to...

May 06, 2024 | Monday | Interview
GDMC Charts a New Course in Genetic Therapy Innovation with Strategic Series A Investment

In an interview with BioPharma BoardRoom, Eric Blair, GDMC’s Chief Business Officer, discusses the company's strategic use of Series A funding to pio...

February 14, 2024 | Wednesday | Interview
These worms have rhythm

Cold Spring Harbor Laboratory (CSHL) Professor Christopher Hammell has found that in the worm C. elegans, this genetic orchestra has no single conduct...

December 28, 2023 | Thursday | News
Unleash the Future of Drug Discovery with Molecule GEN: Your AI Odyssey Begins Here!

In the fast-paced realm of drug discovery, Molecule GEN stands as a beacon of innovation, promising a quantum leap in the way we approach pharmaceutical br...

December 03, 2023 | Sunday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close